Merger of Personalis at $16.25/share under legal investigation for fairness and fiduciary duty concerns

Bleichmar Fonti & Auld LLP is investigating the $16.25 per share merger where Tempus AI plans to take Personalis private. The investigation focuses on potential breaches of fiduciary duty due to Tempus AI's prior commercial relationship and ownership stake in Personalis. The law firm is assessing if the merger terms comply with Delaware law and whether the offer price is fair to public shareholders. Current Personalis stockholders are encouraged to contact the firm for legal options, with representation on a contingency fee basis.

Personalis (PSNL) shares are trading at USD 15.90 on Pluang as of Nov 09, 2026 17:41 WIB, slightly below the $16.25 merger offer price under investigation. This price is closer to the 52-week high of $18.38 than the low of $5.04, showing the stock remains relatively strong despite the pending legal scrutiny. The 1-day gain of 0.70% indicates modest positive momentum in the health sector stock amid the merger news.